Date | Time | Source | Headline | Symbol | Company |
10/06/2023 | 4:07PM | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section 12(g)] | NASDAQ:RETA | Reata Pharmaceuticals Inc |
09/28/2023 | 4:30PM | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] | NASDAQ:RETA | Reata Pharmaceuticals Inc |
09/26/2023 | 7:18PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
09/26/2023 | 5:25PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:RETA | Reata Pharmaceuticals Inc |
09/26/2023 | 4:30PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
09/26/2023 | 4:30PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
09/26/2023 | 4:30PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
09/26/2023 | 4:30PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
09/26/2023 | 4:30PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
09/26/2023 | 4:30PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
09/26/2023 | 4:30PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
09/26/2023 | 4:30PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
09/26/2023 | 4:30PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
09/26/2023 | 4:30PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
09/26/2023 | 4:30PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
09/26/2023 | 4:30PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
09/26/2023 | 4:25PM | Edgar (US Regulatory) | Form POSASR - Post-effective Amendment to an automatic shelf registration statement | NASDAQ:RETA | Reata Pharmaceuticals Inc |
09/26/2023 | 4:23PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
09/26/2023 | 4:22PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
09/26/2023 | 4:21PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
09/26/2023 | 4:20PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
09/26/2023 | 4:19PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
09/26/2023 | 4:18PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
09/26/2023 | 4:17PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
09/26/2023 | 4:16PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
09/26/2023 | 4:15PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
09/26/2023 | 4:14PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
09/26/2023 | 8:59AM | GlobeNewswire Inc. | Biogen Completes Acquisition of Reata Pharmaceuticals | NASDAQ:RETA | Reata Pharmaceuticals Inc |
09/21/2023 | 4:05PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:RETA | Reata Pharmaceuticals Inc |
09/21/2023 | 10:08AM | Business Wire | Reata Pharmaceuticals Stockholders Approve Merger Transaction With Biogen Inc. | NASDAQ:RETA | Reata Pharmaceuticals Inc |